ArticleFrontiers in endocrinology2026
Machine learning versus traditional regression models for predicting diabetic retinopathy screening adherence among community-dwelling older adults with diabetes.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic retinopathy (DR) is a leading cause of preventable vision loss among patients with diabetes, yet screening adherence remains suboptimal. Existing studies have mainly focused on clinical or sociodemographic determinants, with limited evidence integrating psychological mechanisms. The application of Protection Motivation Theory (PMT)-based constructs combined with machine learning for predicting DR screening adherence remains underexplored in community populations. Objective: This study compared machine learning models (decision tree and random forest) with traditional logistic regression for predicting DR screening adherence among community-dwelling older adults with diabetes, incorporating a validated PMT-based questionnaire as a key psychological predictor. Methods: A cluster random sampling design recruited 1,021 older adults with diabetes from four community health centers in Nantong, China (March-October 2025). Data included sociodemographic characteristics, clinical indicators, health behaviors, and PMT-based constructs. Participants were classified as good (n = 159) or poor adherence (n = 862). SMOTE and class weighting addressed class imbalance. Models were evaluated using 10-fold cross-validation. Logistic regression, decision tree, and random forest models were built using identical predictors. Decision curve analysis assessed clinical utility. Results: The random forest model achieved a marginally higher AUC (0.774, 95% CI: 0.678-0.869) compared with logistic regression (AUC = 0.751, 95% CI: 0.678-0.824) and decision tree (AUC = 0.709, 95% CI: 0.596-0.821); however, DeLong's tests indicated no statistically significant differences (all p > 0.05). The decision tree exhibited the best calibration (lowest Brier score = 0.1142). DCA indicated that random forest provided the highest net benefit across most threshold probabilities. Multivariable analysis identified history of ocular disease (OR = 3.529, 95% CI: 2.430-5.139) as the strongest positive predictor, while higher HbA1c, lower self-efficacy, higher perceived severity, absence of exercise therapy, and smoking were associated with poorer adherence. Conclusion: Machine learning models demonstrated comparable discriminative performance to traditional logistic regression for predicting DR screening adherence, while offering distinct profiles in calibration and clinical net benefit. Integration of PMT-based psychological constructs with clinical and behavioral factors provides a multidimensional framework for understanding screening behavior and supports risk stratification for precision diabetes care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.